Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Use of renin-angiotensin system blockers and posttraumatic stress disorder risk in the UK Biobank: a retrospective cohort study

Autor: Sunghyuk Kang, Jimin Kim, Ji Su Yang, Ye Jin Jeon, Hyeok-Hee Lee, Shakira F. Suglia, Alexander C. Tsai, Jee In Kang, Sun Jae Jung

Publikováno v: BMC Medicine, Vol 22, Iss 1, Pp 1-11 (2024)

Abstract Background Previous research has shown that the use of renin-angiotensin system (RAS) blockers is linked to a lower prevalence of posttraumatic stress disorder (PTSD), but longitudinal studies are scarce. We aimed to estimate the association

Externí odkaz: https://doaj.org/article/e3798d7a84264d04a6b951530fdf3a1e

Cost-effectiveness Analysis of Lercanidipine Compared to Amlodipine as an Addition to Renin-angiotensin System Blockers in Diabetic Hypertensive Patients with Albuminuria in Thailand

Autor: Kamolpat Russameeruttayadham, Wiwat Thavornwattanayong, Piyanut Ueapanjasin, Jadesada Lertsirimunkong

Publikováno v: Siriraj Medical Journal, Vol 76, Iss 8 (2024)

Objective: Dihydropyridine calcium channel blocker (DHP-CCBs) is an appropriate add-on antihypertensive option for uncontrolled blood pressure diabetic hypertensive patients with albuminuria who are already taking renin-angiotensin system blockers (R

Externí odkaz: https://doaj.org/article/6d99b33cd3464452b004624062c18b57

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Primary medication adherence in Medicare beneficiaries prescribed sacubitril-valsartan or renin-angiotensin system blockers for heart failure with reduced ejection fraction.

Autor: Hwang CS; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Division of General Internal Medicine and Geriatrics, Oregon Health and Science University, Portland, OR; Section of General Internal Medicine, VA Portland Health Care System, Portland, OR. Electronic address: hwangca@ohsu.edu., Desai RJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Kesselheim AS; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Levin R; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Rome BN; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

Publikováno v: American heart journal [Am Heart J] 2024 Dec 03; Vol. 281, pp. 84-91. Date of Electronic Publication: 2024 Dec 03.